Acute Lymphoblastic Leukemia in Systemic Lupus Erythematosus Disguise: A Case Report
Journal Title: Journal of Musculoskeletal Disorders and Treatment - Year 2017, Vol 3, Issue 2
Abstract
The present report describes the case of an 18-year-old male exhibiting Acute Lymphocytic Leukemia (ALL). He initially presented with a multitude of rheumatic manifestations that were attributed to Systemic Lupus Erythematosus (SLE). The initial peripheral smear and bone marrow exam did not show any abnormal cells that developed later on along his disease course.
Authors and Affiliations
Keywords
Related Articles
- EP ID EP348108
- DOI 10.23937/2572-3243.1510034
- Views 93
- Downloads 0
The Effects of an Audible Low Frequency Acoustic Waveform on Osteoarthritis: A Pilot Study
Objective:The purpose of this pilot study was to investigate the effects of an audible low frequency acoustic waveform on pain and range of motion (ROM) for patients with osteoarthritis (OA). Methods:Twenty one adults w...
The Chondral Tissue and PRP. Theory to Support the Use
The hyaline cartilage structure is very complex, with few cells, and without blood and lymphatic vessels or nerves. This makes the healing potential very limited. Knee cartilage injuries are very common, and its treatmen...
Current Approaches in Myofunctional Orthodontics
Functional matrix theory is the most widely accepted theory of craniofacial growth recently. Moss and Salentijn, have suggested that the craniofacial growth is the result of the changes in functional matrix. Accordingly,...
Phoenix Project for Improving the Quality of Life in Rheumatic Diseases: Preliminay Results
Rheumatic chronic diseases (RCD) are among the most common chronic non-communicable diseases. They are the leading cause of disability in developed countries, and consume a large amount of health and social resources. T...
Necrotizing Fasciitis without Inflammatory Signs in Patients Receiving Anti-Interleukin-6 Receptor Antibody (Tocilizumab): Two Cases Report
Tocilizumab is a monoclonal antibody directed against the interleukin-6 receptor and used for the treatment of rheumatoid arthritis (RA). However, patients treated with tocilizumab have risk of infection, such as necroti...